CIK 0001896212 · <br>Emerging growth company
CDT Equity Inc.
Sign in to watch- Ticker
- CDT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 873272543
- Phone
- (646) 491 9132
- Business address
- 4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES, FL, 34103
- Former names
- CONDUIT PHARMACEUTICALS INC., Murphy Canyon Acquisition Corp.
Securities
- CDT Common Stock Nasdaq
- CDTTW Warrant Nasdaq
- 3 Insider Initial Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Bylaws or fiscal year change · Other events
- 8-K Event Shareholder vote results
- DRS Other Draft Registration Statement
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement
- SC 13D/A Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Unregistered share sale
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
Page 17 of 19 · 371 filings